Enteral Feeding Formula Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The global Enteral Feeding Formula Market is experiencing robust growth, as revealed in a recent analysis report by Fairfield Market Research. In 2024, the market's global sales reached US$ 6.99 billion. The market is projected to attain a valuation of US$ 13.1 billion by 2031, with the Standard Formula segment expected to be the highest revenue-generating segment during 2024 to 2031.

Factors Driving Enteral Feeding Formula Demand

The enteral feeding formula market is being propelled by several key factors. An aging population and the increasing demand for home care services are primary drivers of market growth. Additionally, the development of cost-effective and efficacious diabetes medications, coupled with heightened awareness of diabetes self-management and government support, contribute significantly to the expansion of the market. Factors such as a rise in preterm deliveries and an increase in malnutrition among hospitalized children are further boosting the demand for enteral feeding formulas.

Factors Impeding Market Growth

While the enteral nutrition market is on a growth trajectory, it faces challenges related to adverse effects and complications associated with enteral feedings. Aggressive enteral feeding may elevate the risk of aspiration or vomiting in children with gastroesophageal reflux. Other drawbacks include diarrhea, skin breakdown, and anatomical disturbances. Mechanical drawbacks such as dislodged or clogged feeding tubes also pose challenges. Moreover, in low- and medium-income countries, a lack of awareness about healthcare, diet, and proper nutrition acts as a significant impediment to the global enteral nutrition market's growth.

Region-wise Analysis

North America Dominates the Market

In 2022, North America emerged as the leader in the global Enteral Feeding Formula market, driven by factors like an aging population, increased preterm births, and a growing number of patients with chronic illnesses. The preference for home-based enteral treatment has also reduced hospital and clinic visits. The rising prevalence of malnutrition further fuels market expansion in the region.

Country-wise Analysis

U.S. Leads the Way

The United States is expected to capture the highest market share by the end of 2031. The expanding elderly population and the prevalence of chronic illnesses are contributing to increased hospitalizations. Additionally, the rising number of premature births, which currently stands at around 15 million according to the WHO, is expected to further drive market growth throughout the forecast period.

U.K. Enteral Feeding Formula Market Overview

The U.K. enteral feeding formula market is set for substantial growth over the forecast period from 2024 to 2031. While specific numerical values have been omitted, this market is expected to exhibit a significant increase in valuation and absolute dollar opportunity during this period.

Japan Enteral Feeding Formula Market Overview

Japan's enteral feeding formula market is also anticipated to witness notable growth through 2031, with a strong absolute dollar opportunity and a steady compound annual growth rate (CAGR).

South Korea Enteral Feeding Formula Market Overview

South Korea's enteral feeding formula market is projected to experience growth between 2024 and 2031, with an expected CAGR and an absolute dollar opportunity during this timeframe.

Competitive Landscape

Leading players in the enteral feeding formula market include,

Danone
Nestle Nutrition
Abbott Nutrition
Mead Johnson & Company
Fresenius Kabi AG
B. Braun Melsungen AG
Otsuka Holdings Co. Ltd.
Nutritional Medicinals, LLC
Kate Farms
Medtrition Inc.
Victus, Inc.
Global Health Products, Inc.
Meiji Holdings
Reckitt Benckiser Group

Segments Covered in Enteral Feeding Formula Market Analysis

By Product Type

Standard Formula
Disease-specific Formula

By Flow Type

Intermittent Feeding Flow
Continuous Feeding Flow

By Stage

Adult
Paediatric

By Indication

Alzheimer's
Nutrition Deficiency
Cancer Care
Diabetes
Chronic Kidney Diseases
Orphan Diseases
Dysphagia
Pain Management
Malabsorption/GI Disorder/Diarrhoea
Other Indications

By Region

North America
Latin America
Europe
APAC
MEA

1. Executive Summary

1.1. Global Enteral Feeding Formula Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Enteral Feeding Formula Market Outlook, 2018 - 2031

3.1. Global Enteral Feeding Formula Market Outlook, by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Standard Formula
  - 3.1.1.2. Disease-specific Formula
3.2. Global Enteral Feeding Formula Market Outlook, by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Intermittent Feeding Flow
  - 3.2.1.2. Continuous Feeding Flow
3.3. Global Enteral Feeding Formula Market Outlook, by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Adult
  - 3.3.1.2. Paediatric
3.4. Global Enteral Feeding Formula Market Outlook, by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. Alzheimer's
  - 3.4.1.2. Nutrition Deficiency
  - 3.4.1.3. Cancer Care
  - 3.4.1.4. Diabetes
  - 3.4.1.5. Chronic Kidney Diseases
  - 3.4.1.6. Orphan Diseases
  - 3.4.1.7. Dysphagia
  - 3.4.1.8. Pain Management
  - 3.4.1.9. Malabsorption/GI Disorder/Diarrhoea
  - 3.4.1.10. Other Indications
3.5. Global Enteral Feeding Formula Market Outlook, by Region, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 3.5.1. Key Highlights
  - 3.5.1.1. North America
  - 3.5.1.2. Europe
  - 3.5.1.3. Asia Pacific
  - 3.5.1.4. Latin America
  - 3.5.1.5. Middle East & Africa

4. North America Enteral Feeding Formula Market Outlook, 2018 - 2031

4.1. North America Enteral Feeding Formula Market Outlook, by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Standard Formula
  - 4.1.1.2. Disease-specific Formula
4.2. North America Enteral Feeding Formula Market Outlook, by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Intermittent Feeding Flow
  - 4.2.1.2. Continuous Feeding Flow
4.3. North America Enteral Feeding Formula Market Outlook, by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Adult
  - 4.3.1.2. Paediatric
4.4. North America Enteral Feeding Formula Market Outlook, by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. Alzheimer's
  - 4.4.1.2. Nutrition Deficiency
  - 4.4.1.3. Cancer Care
  - 4.4.1.4. Diabetes
  - 4.4.1.5. Chronic Kidney Diseases
  - 4.4.1.6. Orphan Diseases
  - 4.4.1.7. Dysphagia
  - 4.4.1.8. Pain Management
  - 4.4.1.9. Malabsorption/GI Disorder/Diarrhoea
  - 4.4.1.10. Other Indications
4.5. North America Enteral Feeding Formula Market Outlook, by Country, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 4.5.1. Key Highlights
  - 4.5.1.1. U.S. Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 4.5.1.2. U.S. Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 4.5.1.3. U.S. Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 4.5.1.4. U.S. Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 4.5.1.5. Canada Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 4.5.1.6. Canada Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 4.5.1.7. Canada Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 4.5.1.8. Canada Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Enteral Feeding Formula Market Outlook, 2018 - 2031

5.1. Europe Enteral Feeding Formula Market Outlook, by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Standard Formula
  - 5.1.1.2. Disease-specific Formula
5.2. Europe Enteral Feeding Formula Market Outlook, by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Intermittent Feeding Flow
  - 5.2.1.2. Continuous Feeding Flow
5.3. Europe Enteral Feeding Formula Market Outlook, by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Adult
  - 5.3.1.2. Paediatric
5.4. Europe Enteral Feeding Formula Market Outlook, by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Alzheimer's
  - 5.4.1.2. Nutrition Deficiency
  - 5.4.1.3. Cancer Care
  - 5.4.1.4. Diabetes
  - 5.4.1.5. Chronic Kidney Diseases
  - 5.4.1.6. Orphan Diseases
  - 5.4.1.7. Dysphagia
  - 5.4.1.8. Pain Management
  - 5.4.1.9. Malabsorption/GI Disorder/Diarrhoea
  - 5.4.1.10. Other Indications
5.5. Europe Enteral Feeding Formula Market Outlook, by Country, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 5.5.1. Key Highlights
  - 5.5.1.1. Germany Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.2. Germany Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.3. Germany Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.4. Germany Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.5. U.K. Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.6. U.K. Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.7. U.K. Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.8. U.K. Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.9. France Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.10. France Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.11. France Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.12. France Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.13. Italy Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.14. Italy Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.15. Italy Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.16. Italy Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.17. Turkey Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.18. Turkey Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.19. Turkey Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.20. Turkey Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.21. Russia Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.22. Russia Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.23. Russia Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.24. Russia Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.25. Rest of Europe Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.26. Rest of Europe Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.27. Rest of Europe Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 5.5.1.28. Rest of Europe Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Enteral Feeding Formula Market Outlook, 2018 - 2031

6.1. Asia Pacific Enteral Feeding Formula Market Outlook, by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Standard Formula
  - 6.1.1.2. Disease-specific Formula
6.2. Asia Pacific Enteral Feeding Formula Market Outlook, by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Intermittent Feeding Flow
  - 6.2.1.2. Continuous Feeding Flow
6.3. Asia Pacific Enteral Feeding Formula Market Outlook, by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Adult
  - 6.3.1.2. Paediatric
6.4. Asia Pacific Enteral Feeding Formula Market Outlook, by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Alzheimer's
  - 6.4.1.2. Nutrition Deficiency
  - 6.4.1.3. Cancer Care
  - 6.4.1.4. Diabetes
  - 6.4.1.5. Chronic Kidney Diseases
  - 6.4.1.6. Orphan Diseases
  - 6.4.1.7. Dysphagia
  - 6.4.1.8. Pain Management
  - 6.4.1.9. Malabsorption/GI Disorder/Diarrhoea
  - 6.4.1.10. Other Indications
6.5. Asia Pacific Enteral Feeding Formula Market Outlook, by Country, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 6.5.1. Key Highlights
  - 6.5.1.1. China Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.2. China Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.3. China Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.4. China Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.5. Japan Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.6. Japan Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.7. Japan Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.8. Japan Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.9. South Korea Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.10. South Korea Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.11. South Korea Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.12. South Korea Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.13. India Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.14. India Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.15. India Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.16. India Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.17. Southeast Asia Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.18. Southeast Asia Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.19. Southeast Asia Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.20. Southeast Asia Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.21. Rest of Asia Pacific Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.22. Rest of Asia Pacific Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.23. Rest of Asia Pacific Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 6.5.1.24. Rest of Asia Pacific Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Enteral Feeding Formula Market Outlook, 2018 - 2031

7.1. Latin America Enteral Feeding Formula Market Outlook, by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Standard Formula
  - 7.1.1.2. Disease-specific Formula
7.2. Latin America Enteral Feeding Formula Market Outlook, by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
7.3. Latin America Enteral Feeding Formula Market Outlook, by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Adult
  - 7.3.1.2. Paediatric
7.4. Latin America Enteral Feeding Formula Market Outlook, by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Alzheimer's
  - 7.4.1.2. Nutrition Deficiency
  - 7.4.1.3. Cancer Care
  - 7.4.1.4. Diabetes
  - 7.4.1.5. Chronic Kidney Diseases
  - 7.4.1.6. Orphan Diseases
  - 7.4.1.7. Dysphagia
  - 7.4.1.8. Pain Management
  - 7.4.1.9. Malabsorption/GI Disorder/Diarrhoea
  - 7.4.1.10. Other Indications
7.5. Latin America Enteral Feeding Formula Market Outlook, by Country, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Brazil Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 7.5.1.2. Brazil Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 7.5.1.3. Brazil Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 7.5.1.4. Brazil Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 7.5.1.5. Mexico Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 7.5.1.6. Mexico Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 7.5.1.7. Mexico Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 7.5.1.8. Mexico Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 7.5.1.9. Argentina Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 7.5.1.10. Argentina Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 7.5.1.11. Argentina Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 7.5.1.12. Argentina Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 7.5.1.13. Rest of Latin America Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 7.5.1.14. Rest of Latin America Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 7.5.1.15. Rest of Latin America Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 7.5.1.16. Rest of Latin America Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Enteral Feeding Formula Market Outlook, 2018 - 2031

8.1. Middle East & Africa Enteral Feeding Formula Market Outlook, by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Standard Formula
  - 8.1.1.2. Disease-specific Formula
8.2. Middle East & Africa Enteral Feeding Formula Market Outlook, by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Intermittent Feeding Flow
  - 8.2.1.2. Continuous Feeding Flow
8.3. Middle East & Africa Enteral Feeding Formula Market Outlook, by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Adult
  - 8.3.1.2. Paediatric
8.4. Middle East & Africa Enteral Feeding Formula Market Outlook, by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Alzheimer's
  - 8.4.1.2. Nutrition Deficiency
  - 8.4.1.3. Cancer Care
  - 8.4.1.4. Diabetes
  - 8.4.1.5. Chronic Kidney Diseases
  - 8.4.1.6. Orphan Diseases
  - 8.4.1.7. Dysphagia
  - 8.4.1.8. Pain Management
  - 8.4.1.9. Malabsorption/GI Disorder/Diarrhoea
  - 8.4.1.10. Other Indications
8.5. Middle East & Africa Enteral Feeding Formula Market Outlook, by Country, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 8.5.1. Key Highlights
  - 8.5.1.1. GCC Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 8.5.1.2. GCC Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 8.5.1.3. GCC Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 8.5.1.4. GCC Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 8.5.1.5. South Africa Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 8.5.1.6. South Africa Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 8.5.1.7. South Africa Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 8.5.1.8. South Africa Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 8.5.1.9. Egypt Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 8.5.1.10. Egypt Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 8.5.1.11. Egypt Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 8.5.1.12. Egypt Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 8.5.1.13. Nigeria Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 8.5.1.14. Nigeria Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 8.5.1.15. Nigeria Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 8.5.1.16. Nigeria Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 8.5.1.17. Rest of Middle East & Africa Enteral Feeding Formula Market by Product Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 8.5.1.18. Rest of Middle East & Africa Enteral Feeding Formula Market by Flow Type, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 8.5.1.19. Rest of Middle East & Africa Enteral Feeding Formula Market by Stage, Value (US$ Bn) and Volume (Tons), 2018 - 2031
  - 8.5.1.20. Rest of Middle East & Africa Enteral Feeding Formula Market by Indication, Value (US$ Bn) and Volume (Tons), 2018 - 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. by Stage vs by Flow Type Heatmap
9.2. Manufacturer vs by Flow Type Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Danone
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Nestle Nutrition
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. Abbott Nutrition
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Mead Johnson & Company
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Fresenius Kabi AG
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. B. Braun Melsungen AG
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. Otsuka Holdings Co. Ltd.
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. Nutritional Medicinals, LLC
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. Kate Farms
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development
- 9.5.10. Medtrition Inc.
  - 9.5.10.1. Company Overview
  - 9.5.10.2. Product Portfolio
  - 9.5.10.3. Financial Overview
  - 9.5.10.4. Business Strategies and Development
- 9.5.11. Victus, Inc.
  - 9.5.11.1. Company Overview
  - 9.5.11.2. Product Portfolio
  - 9.5.11.3. Financial Overview
  - 9.5.11.4. Business Strategies and Development
- 9.5.12. Global Health Products, Inc.
  - 9.5.12.1. Company Overview
  - 9.5.12.2. Product Portfolio
  - 9.5.12.3. Financial Overview
  - 9.5.12.4. Business Strategies and Development
- 9.5.13. Meiji Holdings
  - 9.5.13.1. Company Overview
  - 9.5.13.2. Product Portfolio
  - 9.5.13.3. Financial Overview
  - 9.5.13.4. Business Strategies and Development
- 9.5.14. Reckitt Benckiser Group
  - 9.5.14.1. Company Overview
  - 9.5.14.2. Product Portfolio
  - 9.5.14.3. Financial Overview
  - 9.5.14.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations